Federal purchases of biological drugs for cancer in Brazil

Biosimilars/Research | Posted 24/09/2021 comments 0
Cancer Cell V13I20

Buying biosimilars is generally considered to be a way to increase access to cancer treatments in public health services. In Europe, the approval, commercialization and use of similar biotherapeuti...

More >
LATIN AMERICAN FORUM
138 AA011155
GMP certification requirements in Argentina, Brazil and Mexico
Posted 17/09/2021

Marketing authorisation (MA) of a medicinal product is the process of reviewing and ass...

138 AA011155
MERCOSUR: new tariff for biological and biosimilar without Latin equity
Posted 03/09/2021

Within the pharmaceutical industry, the biosimilars business is growing and consolidati...

16704526_l
GABiC proposes the use of biosimilars as strategy for innovation and sustainability
Posted 10/09/2021

The commitment to biosimilars as a strategy to promote innovation and sustainability is...

Home/Non‐Biological Complex Drugs
Liposome V15L11

On 4 April 2018, the US Food and Drug Administration (FDA) issued a new draft guidance...

More >

Generics

New five-year medicines agreements in Australia
Generics/General | Posted 24/09/2021
Generic pharmaceutical policies in the MENA region
Generics/Research | Posted 17/09/2021
Sandoz launches ferumoxytol and pemetrexed generics
Generics/News | Posted 03/09/2021
Generics applications under review by EMA – July 2021
Generics/General | Posted 23/07/2021

Biosimilars

Federal purchases of biological drugs for cancer in Brazil
Biosimilars/Research | Posted 24/09/2021
Biosimilars approved in Uruguay
Biosimilars/General | Posted 24/09/2021